Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337762305> ?p ?o ?g. }
- W2337762305 endingPage "433" @default.
- W2337762305 startingPage "424" @default.
- W2337762305 abstract "More than 2000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) have been described that confer a range of molecular cell biological and functional phenotypes. Most of these mutations lead to compromised anion conductance at the apical plasma membrane of secretory epithelia and cause cystic fibrosis (CF) with variable disease severity. Based on the molecular phenotypic complexity of CFTR mutants and their susceptibility to pharmacotherapy, it has been recognized that mutations may impose combinatorial defects in CFTR channel biology. This notion led to the conclusion that the combination of pharmacotherapies addressing single defects (e.g., transcription, translation, folding, and/or gating) may show improved clinical benefit over available low-efficacy monotherapies. Indeed, recent phase 3 clinical trials combining ivacaftor (a gating potentiator) and lumacaftor (a folding corrector) have proven efficacious in CF patients harboring the most common mutation (deletion of residue F508, ΔF508, or Phe508del). This drug combination was recently approved by the U.S. Food and Drug Administration for patients homozygous for ΔF508. Emerging studies of the structural, cell biological, and functional defects caused by rare mutations provide a new framework that reveals a mixture of deficiencies in different CFTR alleles. Establishment of a set of combinatorial categories of the previously defined basic defects in CF alleles will aid the design of even more efficacious therapeutic interventions for CF patients." @default.
- W2337762305 created "2016-06-24" @default.
- W2337762305 creator A5003537359 @default.
- W2337762305 creator A5004896108 @default.
- W2337762305 creator A5007894424 @default.
- W2337762305 creator A5009320465 @default.
- W2337762305 creator A5011908120 @default.
- W2337762305 creator A5019426685 @default.
- W2337762305 creator A5023506885 @default.
- W2337762305 creator A5026190252 @default.
- W2337762305 creator A5029220053 @default.
- W2337762305 creator A5030361320 @default.
- W2337762305 creator A5032638121 @default.
- W2337762305 creator A5050704941 @default.
- W2337762305 creator A5052136826 @default.
- W2337762305 creator A5058003677 @default.
- W2337762305 creator A5066829790 @default.
- W2337762305 creator A5079375370 @default.
- W2337762305 creator A5084791829 @default.
- W2337762305 creator A5091626287 @default.
- W2337762305 date "2016-02-01" @default.
- W2337762305 modified "2023-10-17" @default.
- W2337762305 title "From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations" @default.
- W2337762305 cites W120703973 @default.
- W2337762305 cites W1502730307 @default.
- W2337762305 cites W1589654967 @default.
- W2337762305 cites W1677528798 @default.
- W2337762305 cites W1910988217 @default.
- W2337762305 cites W1969875074 @default.
- W2337762305 cites W1975971473 @default.
- W2337762305 cites W1976197028 @default.
- W2337762305 cites W1979869569 @default.
- W2337762305 cites W1982956224 @default.
- W2337762305 cites W1984005894 @default.
- W2337762305 cites W1988397255 @default.
- W2337762305 cites W1990670389 @default.
- W2337762305 cites W1990725675 @default.
- W2337762305 cites W1991456846 @default.
- W2337762305 cites W1995692151 @default.
- W2337762305 cites W1996214757 @default.
- W2337762305 cites W1996779865 @default.
- W2337762305 cites W1997489109 @default.
- W2337762305 cites W1998953032 @default.
- W2337762305 cites W2004155358 @default.
- W2337762305 cites W2010844072 @default.
- W2337762305 cites W2013914743 @default.
- W2337762305 cites W2016446741 @default.
- W2337762305 cites W2024429650 @default.
- W2337762305 cites W2028171116 @default.
- W2337762305 cites W2030955600 @default.
- W2337762305 cites W2032815975 @default.
- W2337762305 cites W2035131077 @default.
- W2337762305 cites W2037922224 @default.
- W2337762305 cites W2039436880 @default.
- W2337762305 cites W2039462910 @default.
- W2337762305 cites W2039599894 @default.
- W2337762305 cites W2043524902 @default.
- W2337762305 cites W2046556853 @default.
- W2337762305 cites W2049696186 @default.
- W2337762305 cites W2049914201 @default.
- W2337762305 cites W2051296698 @default.
- W2337762305 cites W2051791025 @default.
- W2337762305 cites W2052116964 @default.
- W2337762305 cites W2052588826 @default.
- W2337762305 cites W2054076148 @default.
- W2337762305 cites W2062515693 @default.
- W2337762305 cites W2063028064 @default.
- W2337762305 cites W2066722784 @default.
- W2337762305 cites W2068688363 @default.
- W2337762305 cites W2071407356 @default.
- W2337762305 cites W2075257287 @default.
- W2337762305 cites W2076138292 @default.
- W2337762305 cites W2078078890 @default.
- W2337762305 cites W2078866884 @default.
- W2337762305 cites W2080854798 @default.
- W2337762305 cites W2082968284 @default.
- W2337762305 cites W2085811948 @default.
- W2337762305 cites W2086293424 @default.
- W2337762305 cites W2086648922 @default.
- W2337762305 cites W2089214886 @default.
- W2337762305 cites W2089942817 @default.
- W2337762305 cites W2091317180 @default.
- W2337762305 cites W2094723274 @default.
- W2337762305 cites W2099252894 @default.
- W2337762305 cites W2104953797 @default.
- W2337762305 cites W2115046089 @default.
- W2337762305 cites W2115127888 @default.
- W2337762305 cites W2116587201 @default.
- W2337762305 cites W2116885714 @default.
- W2337762305 cites W2117472380 @default.
- W2337762305 cites W2119745826 @default.
- W2337762305 cites W2121996960 @default.
- W2337762305 cites W2122484880 @default.
- W2337762305 cites W2122967691 @default.
- W2337762305 cites W2123987449 @default.
- W2337762305 cites W2125639616 @default.
- W2337762305 cites W2128903674 @default.
- W2337762305 cites W2130444133 @default.